U.S. FDA declines to approve J & J arthritis drug

(Reuters) - The U.S. Food and Drug Administration has declined to approve Johnson& Johnson's rheumatoid arthritis drug sirukumab, saying additional clinical data is needed to further evaluate its safety, the company said on Friday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news